Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoon-Jae Cho

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
Cold Spring Harbor Molecular Case Studies|August 25, 2021
Mechanisms of targeted therapy resistance in a pediatric glioma driven by <i>ETV6-NTRK3</i> fusionClare Keddy, Tanaya Neff, Jianya Huan, et al.
JAMA Network Open|October 16, 2024
In Utero Exposure to Maternal COVID-19 and Offspring Neurodevelopment Through Age 24 MonthsEleni G Jaswa, Heather G Huddleston, Karla J Lindquist, et al.
Advances in Radiation Oncology|April 14, 2020
Measure Twice: Promise of Liquid Biopsy in Pediatric High-Grade GliomasMatthew S Dietz, Catherine Z Beach, Ramon Barajas, et al.
Acta Neuropathologica|March 10, 2012
Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastomaShyamal Dilhan Weeraratne, Vladimir Amani, Natalia Teider, et al.
Acta Neuropathologica|December 3, 2011
Molecular subgroups of medulloblastoma: the current consensusMichael D Taylor, Paul A Northcott, Andrey Korshunov, et al.
Oncotarget|May 14, 2015
Proteomic profiling of high risk medulloblastoma reveals functional biologyJerome A Staal, Ling San Lau, Huizhen Zhang, et al.
Acta Neuropathologica|November 8, 2011
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samplesPaul A Northcott, David J H Shih, Marc Remke, et al.
The EMBO Journal|September 15, 2016
FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastomaAldwin Suryo Rahmanto, Vasil Savov, Andrä Brunner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcomeYoon-Jae Cho, Aviad Tsherniak, Pablo Tamayo, et al.
Molecular Cancer Research : MCR|August 31, 2017
A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven Lung CancerZachary A Yochum, Jessica Cades, Lucia Mazzacurati, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Cold Spring Harbor Molecular Case Studies|August 25, 2021
Mechanisms of targeted therapy resistance in a pediatric glioma driven by <i>ETV6-NTRK3</i> fusionClare Keddy, Tanaya Neff, Jianya Huan, et al.
JAMA Network Open|October 16, 2024
In Utero Exposure to Maternal COVID-19 and Offspring Neurodevelopment Through Age 24 MonthsEleni G Jaswa, Heather G Huddleston, Karla J Lindquist, et al.
Advances in Radiation Oncology|April 14, 2020
Measure Twice: Promise of Liquid Biopsy in Pediatric High-Grade GliomasMatthew S Dietz, Catherine Z Beach, Ramon Barajas, et al.
Acta Neuropathologica|March 10, 2012
Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastomaShyamal Dilhan Weeraratne, Vladimir Amani, Natalia Teider, et al.
Acta Neuropathologica|December 3, 2011
Molecular subgroups of medulloblastoma: the current consensusMichael D Taylor, Paul A Northcott, Andrey Korshunov, et al.
Oncotarget|May 14, 2015
Proteomic profiling of high risk medulloblastoma reveals functional biologyJerome A Staal, Ling San Lau, Huizhen Zhang, et al.
Acta Neuropathologica|November 8, 2011
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samplesPaul A Northcott, David J H Shih, Marc Remke, et al.
The EMBO Journal|September 15, 2016
FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastomaAldwin Suryo Rahmanto, Vasil Savov, Andrä Brunner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcomeYoon-Jae Cho, Aviad Tsherniak, Pablo Tamayo, et al.
Molecular Cancer Research : MCR|August 31, 2017
A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven Lung CancerZachary A Yochum, Jessica Cades, Lucia Mazzacurati, et al.
Pageof 13